Gutenberg Teaching Council of Johannes Gutenberg University Mainz supports project in Pharmaceutical Sciences with about EUR 60,000
Students of Pharmaceutical Sciences at Johannes Gutenberg University Mainz (JGU) can now opt for taking a more research-oriented approach to their subject by exploring the latest techniques to create new active drug substances.
In lectures and practical courses, they learn about a selection of computer-based methods that the pharmaceutical industry already routinely uses for computer-aided drug design. Computer-aided drug design (CADD) is one of the mainstays of modern drug development.
Therefore, JGU's Institute of Pharmaceutical Sciences and Biochemistry has recently acquired a 3-D projector that visually demonstrates to students how drugs interact with their target structures in the body, i.e., proteins.
"Our objective is to introduce all students of Pharmaceutical Sciences and Biomedical Chemistry to the basics of computer-aided drug design because this method is now in standard use in the pharmaceutical industry. It is also an integral part of our research here at the institute," explained Junior Professor Ruth Brenk, who initiated the project.
The Gutenberg Teaching Council (GTC) of Mainz University has provided nearly EUR 60,000 to support this research-oriented teaching project. The fact that the students are queuing up to take part in the elective module on CADD demonstrates that this was a worthwhile investment in modern learning and teaching.
The new setup of 3-D projections is used in seminars and lectures and has been put together by the institute itself using a projector, software, and a graphics card. Equipped with 3-D glasses, students can follow on a special metalized silver screen how and where proteins, with their three-dimensional structure, provide an access point for drugs, and how protein and ligand interact.
"Through demonstrations and through practical exercises and, of course, with the relevant teaching support, students can be made sufficiently familiar with the new techniques in a relatively short period of time so that they can then apply these themselves to independently work on current research topics", Brenk summarized the advantages. CAAD lectures and practical courses have since become standard parts of the course of study at the Institute of Pharmaceutical Sciences and Biochemistry at Mainz University.
Junior Professor Dr. Ruth Brenk
Institute of Pharmaceutical Sciences and Biochemistry – Therapeutic Life Sciences
Johannes Gutenberg University Mainz (JGU)
55099 Mainz, GERMANY
phone +49 6131 39-25726
fax +49 6131 39-25670
http://www.uni-mainz.de/presse/19406_ENG_HTML.php - press release ;
http://www.pharmazie.uni-mainz.de/index_eng.php - Institute of Pharmacy and Biochemistry – Therapeutical Life Sciences ;
http://www.pharmazie.uni-mainz.de/AK-Brenk/ - Brenk Group ;
http://www.glk.uni-mainz.de/index_ENG.php - Gutenberg Teaching Council (GTC)
Petra Giegerich | idw - Informationsdienst Wissenschaft
The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences
Transforming plant cells from generalists to specialists
07.12.2016 | Duke University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine